tetano
Editor, Senior Moderator
The Lancet Infectious Diseases, Volume 14, Issue 2, Pages 88 - 89, February 2014
doi:10.1016/S1473-3099(13)70287-1Cite or Link Using DOI
Published Online: 22 November 2013
Copyright ? 2014 Elsevier Ltd All rights reserved.
Optimum timing of oseltamivir: lessons from Bangladesh
Michael G Ison aEmail Address
Widespread resistance in currently circulating influenza A viruses has reduced the options for antiviral therapy against influenza. 1 , 2 Neuraminidase inhibitors, including laninamivir, oseltamivir, peramivir, and zanamivir, are the only approved anti-influenza drugs that have proven activity against circulating strains of influenza A and B viruses worldwide. 3 Oseltamivir is available in both pill and oral suspension formulations that can be given safely to patients of any age. 4?7 Furthermore, oselta ...
http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(13)70287-1/fulltext?rss=yes
doi:10.1016/S1473-3099(13)70287-1Cite or Link Using DOI
Published Online: 22 November 2013
Copyright ? 2014 Elsevier Ltd All rights reserved.
Optimum timing of oseltamivir: lessons from Bangladesh
Michael G Ison aEmail Address
Widespread resistance in currently circulating influenza A viruses has reduced the options for antiviral therapy against influenza. 1 , 2 Neuraminidase inhibitors, including laninamivir, oseltamivir, peramivir, and zanamivir, are the only approved anti-influenza drugs that have proven activity against circulating strains of influenza A and B viruses worldwide. 3 Oseltamivir is available in both pill and oral suspension formulations that can be given safely to patients of any age. 4?7 Furthermore, oselta ...
http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(13)70287-1/fulltext?rss=yes